Gene · 3741
Papers2,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pilot Study of Use of Nitric Oxide in Monitoring Multiple Dental Foci in Oral Cavity-A Case Report. | Healthcare (Basel) | 2022 | 35206810 | PubTator, text mining | PubMed |
| Channelopathy Genes in Pulmonary Arterial Hypertension. | Biomolecules | 2022 | 35204766 | PubTator, text mining | PubMed |
| The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open state. | Korean J Physiol Pharmacol | 2022 | 35203063 | PubTator, text mining | PubMed |
| A Tale of Toxin Promiscuity: The Versatile Pharmacological Effects of Hcr 1b-2 Sea Anemone Peptide on Voltage-Gated Ion Channels. | Mar Drugs | 2022 | 35200676 | PubTator, text mining | PubMed |
| Nuclear Transporting Factor 2 as a Novel Biomarker of Head and Neck Squamous Cell Carcinoma and Associated with T/B Cell Receptor Signaling Pathway. | Biomed Res Int | 2022 | 35155672 | PubTator, text mining | PubMed |
| Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases. | J Transl Autoimmun | 2022 | 35146402 | PubTator, text mining | PubMed |
| Feasibility and safety of targeting mitochondria for cancer therapy - preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor. | Cancer Biol Ther | 2022 | 35129069 | PubTator, text mining | PubMed |
| Review: HCN Channels in the Heart. | Curr Cardiol Rev | 2022 | 35125083 | PubTator, text mining | PubMed |
| Depolarization or hyperpolarization: Emerging role of altered bioelectricity in breast cancer metastasis. | EBioMedicine | 2022 | 35104786 | PubTator, text mining | PubMed |
| High spatial density is associated with non-conducting Kv channels from two families. | Biophys J | 2022 | 35101417 | PubTator, text mining | PubMed |
| Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology. | Cells | 2022 | 35053315 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors. | J Enzyme Inhib Med Chem | 2022 | 35012386 | PubTator, text mining | PubMed |
| Alternative Targets for Modulators of Mitochondrial Potassium Channels. | Molecules | 2022 | 35011530 | PubTator, text mining | PubMed |
| Celebrities in the heart, strangers in the pancreatic beta cell: Voltage-gated potassium channels Kv 7.1 and Kv 11.1 bridge long QT syndrome with hyperinsulinaemia as well as type 2 diabetes. | Acta Physiol (Oxf) | 2022 | 34990074 | PubTator, text mining | PubMed |
| microRNAs and long non-coding RNAs as biomarkers for polycystic ovary syndrome. | J Cell Mol Med | 2022 | 34989136 | PubTator, text mining | PubMed |
| Carbon monoxide activation of delayed rectifier potassium currents of human cardiac fibroblasts through diverse pathways. | Korean J Physiol Pharmacol | 2022 | 34965993 | PubTator, text mining | PubMed |
| Potassium channel-driven bioelectric signalling regulates metastasis in triple-negative breast cancer. | EBioMedicine | 2022 | 34933180 | PubTator, text mining | PubMed |
| Development of an in vitro carcinogenesis model of human papillomavirus-induced cervical adenocarcinoma. | Cancer Sci | 2022 | 34932848 | PubTator, text mining | PubMed |
| Adaptively evolved human oral actinomyces-sourced defensins show therapeutic potential. | EMBO Mol Med | 2022 | 34927385 | PubTator, text mining | PubMed |
| Transgenerational effects on the fecundity and sperm proteome in rats exposed to a mixture of pyrethroids at doses similar to human consumption. | Chemosphere | 2022 | 34896426 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3741/papers?page=20